Open Access
Open access
Evidence-based Complementary and Alternative Medicine, volume 2022, pages 1-11

Identification of Potential WSB1 Inhibitors by AlphaFold Modeling, Virtual Screening, and Molecular Dynamics Simulation Studies

Publication typeJournal Article
Publication date2022-05-13
Quartile SCImago
Q2
Quartile WOS
Impact factor
ISSN1741427X, 17414288
Complementary and alternative medicine
Abstract

WD40 repeat and SOCS box containing 1 (WSB1) consists of seven WD40 repeat structural domains at the N-terminal end and one SOCS box structural domain at the C-terminal end. WSB1 promotes cancer progression by affecting the Von Hippel–Lindau tumor suppressor protein (pVHL) and upregulating hypoxia inducible factor-1α (HIF-1α) target gene expression. However, the crystal structure of WSB1 has not been reported, which is not beneficial to the research on WSB1 inhibitors. Therefore, we focused on specific small molecule inhibitors of WSB1. This study applied virtual screening and molecular dynamics simulations; finally, 20 compounds were obtained. Among them, compound G490-0341 showed the best stable structure and was a promising composite for further development of WSB1 inhibitors.

Top-30

Journals

1
Journal of Chemical Information and Modeling
1 publication, 12.5%
Molecules
1 publication, 12.5%
Microbial Cell Factories
1 publication, 12.5%
Biomolecules
1 publication, 12.5%
Russian Chemical Reviews
1 publication, 12.5%
Chinese Journal of Chemical Engineering
1 publication, 12.5%
1

Publishers

1
2
MDPI
2 publications, 25%
American Chemical Society (ACS)
1 publication, 12.5%
Research Square Platform LLC
1 publication, 12.5%
Springer Nature
1 publication, 12.5%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 12.5%
Cold Spring Harbor Laboratory
1 publication, 12.5%
Elsevier
1 publication, 12.5%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Weng Y. et al. Identification of Potential WSB1 Inhibitors by AlphaFold Modeling, Virtual Screening, and Molecular Dynamics Simulation Studies // Evidence-based Complementary and Alternative Medicine. 2022. Vol. 2022. pp. 1-11.
GOST all authors (up to 50) Copy
Weng Y., Pan C., Shen Z., Chen S., Xu L., Dong X., Chen J. Identification of Potential WSB1 Inhibitors by AlphaFold Modeling, Virtual Screening, and Molecular Dynamics Simulation Studies // Evidence-based Complementary and Alternative Medicine. 2022. Vol. 2022. pp. 1-11.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1155/2022/4629392
UR - https://doi.org/10.1155/2022/4629392
TI - Identification of Potential WSB1 Inhibitors by AlphaFold Modeling, Virtual Screening, and Molecular Dynamics Simulation Studies
T2 - Evidence-based Complementary and Alternative Medicine
AU - Weng, Ye
AU - Pan, Chenghao
AU - Shen, Zheyuan
AU - Chen, Sikang
AU - Xu, Lei
AU - Dong, Xiaowu
AU - Chen, Jing
PY - 2022
DA - 2022/05/13
PB - Hindawi Limited
SP - 1-11
VL - 2022
SN - 1741-427X
SN - 1741-4288
ER -
BibTex
Cite this
BibTex Copy
@article{2022_Weng,
author = {Ye Weng and Chenghao Pan and Zheyuan Shen and Sikang Chen and Lei Xu and Xiaowu Dong and Jing Chen},
title = {Identification of Potential WSB1 Inhibitors by AlphaFold Modeling, Virtual Screening, and Molecular Dynamics Simulation Studies},
journal = {Evidence-based Complementary and Alternative Medicine},
year = {2022},
volume = {2022},
publisher = {Hindawi Limited},
month = {may},
url = {https://doi.org/10.1155/2022/4629392},
pages = {1--11},
doi = {10.1155/2022/4629392}
}
Found error?